182 related articles for article (PubMed ID: 28778369)
1. Discovery of new leads against Mycobacterium tuberculosis using scaffold hopping and shape based similarity.
Wavhale RD; Martis EAF; Ambre PK; Wan B; Franzblau SG; Iyer KR; Raikuvar K; Macegoniuk K; Berlicki Ł; Nandan SR; Coutinho EC
Bioorg Med Chem; 2017 Sep; 25(17):4835-4844. PubMed ID: 28778369
[TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity.
Biava M; Porretta GC; Poce G; Supino S; Deidda D; Pompei R; Molicotti P; Manetti F; Botta M
J Med Chem; 2006 Aug; 49(16):4946-52. PubMed ID: 16884306
[TBL] [Abstract][Full Text] [Related]
3. New derivatives of BM212: A class of antimycobacterial compounds based on the pyrrole ring as a scaffold.
Biava M; Porretta GC; Manetti F
Mini Rev Med Chem; 2007 Jan; 7(1):65-78. PubMed ID: 17266639
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial compounds. New pyrrole derivatives of BM212.
Biava M; Porretta GC; Deidda D; Pompei R; Tafi A; Manetti F
Bioorg Med Chem; 2004 Mar; 12(6):1453-8. PubMed ID: 15018918
[TBL] [Abstract][Full Text] [Related]
5. New pyrrole derivatives as antimycobacterial agents analogs of BM212.
Biava M; Fioravanti R; Porretta GC; Deidda D; Maullu C; Pompei R
Bioorg Med Chem Lett; 1999 Oct; 9(20):2983-8. PubMed ID: 10571160
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant and intramacrophagic Mycobacterium tuberculosis strains.
Deidda D; Lampis G; Fioravanti R; Biava M; Porretta GC; Zanetti S; Pompei R
Antimicrob Agents Chemother; 1998 Nov; 42(11):3035-7. PubMed ID: 9797251
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach.
Magotra A; Sharma A; Singh S; Ojha PK; Kumar S; Bokolia N; Wazir P; Sharma S; Khan IA; Singh PP; Vishwakarma RA; Singh G; Nandi U
Pulm Pharmacol Ther; 2018 Feb; 48():151-160. PubMed ID: 29174840
[TBL] [Abstract][Full Text] [Related]
8. 1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.
Biava M; Porretta GC; Poce G; De Logu A; Saddi M; Meleddu R; Manetti F; De Rossi E; Botta M
J Med Chem; 2008 Jun; 51(12):3644-8. PubMed ID: 18494459
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N'-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria.
Bhakta S; Scalacci N; Maitra A; Brown AK; Dasugari S; Evangelopoulos D; McHugh TD; Mortazavi PN; Twist A; Petricci E; Manetti F; Castagnolo D
J Med Chem; 2016 Mar; 59(6):2780-93. PubMed ID: 26907951
[TBL] [Abstract][Full Text] [Related]
10. Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents.
Ramesh R; Shingare RD; Kumar V; Anand A; B S; Veeraraghavan S; Viswanadha S; Ummanni R; Gokhale R; Srinivasa Reddy D
Eur J Med Chem; 2016 Oct; 122():723-730. PubMed ID: 27476117
[TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class.
Biava M; Porretta GC; Poce G; Deidda D; Pompei R; Tafi A; Manetti F
Bioorg Med Chem; 2005 Feb; 13(4):1221-30. PubMed ID: 15670931
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel carbazole tethered pyrrole derivatives as potent inhibitors of Mycobacterium tuberculosis.
Surineni G; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2015 Feb; 25(3):485-91. PubMed ID: 25559743
[TBL] [Abstract][Full Text] [Related]
13. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of antimycobacterial activity of new benzimidazole aminoesters.
Yoon YK; Ali MA; Wei AC; Choon TS; Ismail R
Eur J Med Chem; 2015 Mar; 93():614-24. PubMed ID: 24996257
[TBL] [Abstract][Full Text] [Related]
15. In vivo potent BM635 analogue with improved drug-like properties.
Poce G; Cocozza M; Alfonso S; Consalvi S; Venditti G; Fernandez-Menendez R; Bates RH; Barros Aguirre D; Ballell L; De Logu A; Vistoli G; Biava M
Eur J Med Chem; 2018 Feb; 145():539-550. PubMed ID: 29335214
[TBL] [Abstract][Full Text] [Related]
16. 1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation.
Biava M; Porretta GC; Poce G; De Logu A; Meleddu R; De Rossi E; Manetti F; Botta M
Eur J Med Chem; 2009 Nov; 44(11):4734-8. PubMed ID: 19595488
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles.
Shingalapur RV; Hosamani KM; Keri RS
Eur J Med Chem; 2009 Oct; 44(10):4244-8. PubMed ID: 19540630
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
[TBL] [Abstract][Full Text] [Related]
19. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
[TBL] [Abstract][Full Text] [Related]
20. Tapping into the antitubercular potential of 2,5-dimethylpyrroles: A structure-activity relationship interrogation.
Semenya D; Touitou M; Masci D; Ribeiro CM; Pavan FR; Dos Santos Fernandes GF; Gianibbi B; Manetti F; Castagnolo D
Eur J Med Chem; 2022 Jul; 237():114404. PubMed ID: 35486992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
